CVSA | Ticker Profile - Titan Protect

CVSA

Covista Inc.

Consumer Defensive · Education & Training Services · NYQ

$126.65

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$4.2B

Total market value of the company

Trailing P/E

17.84

Reasonably valued

Forward P/E

13.86

Based on estimated future earnings — lower means cheaper

Rev Growth

+4.5%

Year-over-year revenue change

Profit Margin

12.3%

How much profit the company keeps from each dollar of revenue

ROE

17.9%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$155.00

+22% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 4 analysts covering this stock

About Covista Inc.

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

https://www.covista.com

Country: United States Employees: 4,703 Industry: Education & Training Services

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.958

Good returns relative to risk taken

Kelly Fraction

0.0989

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

0.887

Acceptable balance between returns and drawdown risk

Annual Return

37.4%

Historical annualised return based on price data

Max Drawdown

-42.1%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.63

Less volatile than the market — more defensive

52W High

$156.26

19% below the year high

52W Low

$86.97

46% above the year low

Avg Volume

329,365

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.9

Days it would take all short sellers to cover — higher means more crowded

Short % Float

6.4%

Moderate short interest

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$6.87

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

53.98

Heavy leverage — higher financial risk if revenues decline

Current Ratio

0.70

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.56

Like current ratio but excludes inventory — stricter test

Gross Margin

57.3%

Revenue left after cost of goods — higher means pricing power

Operating Margin

18.9%

Profit from core operations before interest and tax

Free Cash Flow

$275M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.9B

Total revenue over the last 12 months

Net Income

$250M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$175.00

Target Median

$155.00

Target Low

$140.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go